Summary
- Quantexa is evaluating a UK or US flotation but has not committed to a timetable and can remain private.
- The British data and AI company was valued at $2.6 billion in its 2025 Series F and has since secured a £175 million HMRC contract.
- Its eventual venue will test whether a UK-founded enterprise technology company still sees deeper US public markets as the stronger route to scale.
One of Britain’s larger privately held artificial-intelligence companies is weighing whether its eventual public-market future belongs in London or the United States, as Quantexa considers a flotation after building a multibillion-dollar private valuation and a growing base of government and enterprise contracts.
The London-headquartered data and AI company is evaluating a UK or US listing, although it has not committed to a timetable and can remain privately held if market conditions or its financing needs favour that route. Quantexa has said it has been operationally ready for an IPO since earlier this year, giving it more flexibility over when and where to test public investors.
Its most recent private funding round valued the business at about $2.6 billion, while the company has continued to expand through large enterprise and public-sector contracts. In May, HM Revenue & Customs awarded Quantexa a 10-year deal worth up to £175 million to provide data and analytics technology used in tax compliance and fraud work.
The choice of exchange therefore goes beyond the mechanics of raising capital. Quantexa was founded and remains headquartered in Britain, but a US listing offers access to deeper technology-focused capital markets and, historically, higher valuations for software businesses with global ambitions.
Public contracts raise the stakes
Quantexa’s platform brings together fragmented organisational data and applies analytics and AI to identify relationships, anomalies, and risks across large datasets. Banks, insurers, government agencies, and other regulated organisations use that approach for fraud detection, financial-crime compliance, customer intelligence, and operational decision-making.
Large public contracts strengthen the revenue profile that investors would examine in an IPO, although they also increase scrutiny of delivery. The HMRC agreement runs over a decade and puts Quantexa into a system whose performance affects tax enforcement and public revenue, raising the consequences of outages, poor data quality, or implementation delays.
Enterprise AI businesses face a different public-market test from companies whose valuations depend primarily on consumer growth. Investors can examine contract duration, recurring revenue, customer concentration, implementation costs, and renewal rates, which makes operational performance harder to separate from the technology narrative.
AI valuations meet enterprise reality
Private AI valuations have risen rapidly as capital has flowed into model developers, infrastructure providers, and software companies capable of attaching AI to established business processes. Yet public markets tend to demand clearer evidence that growth can translate into durable margins and cash generation, particularly once a company reaches the scale where large contracts require substantial implementation and support teams.
Quantexa has an advantage in selling into areas where data complexity already creates a budget line. Fraud, anti-money-laundering controls, compliance, and tax administration are not discretionary experiments, although customers still have to justify new platform spending against existing data systems and internal technology programmes.
That can make the company’s AI exposure more defensible than a product built around a single generative interface, but it also means growth depends on integration with messy legacy estates. Public investors would be buying into a software company whose value comes partly from making difficult enterprise data usable rather than from model capability alone.
London has something to prove
Any eventual decision between London and the US would arrive amid a long-running debate over the depth of Britain’s public technology markets. UK policymakers have tried to make London more attractive to high-growth companies through listing reforms and institutional-investment changes, while several British-founded technology businesses have still chosen US exchanges in pursuit of larger pools of specialist capital.
For Quantexa, the decision can remain open while private funding and contract revenue support continued expansion. That bargaining position is useful because an IPO is most valuable when it gives the company access to capital on acceptable terms rather than becoming a deadline imposed by existing investors.
The venue will nevertheless be watched as another test of whether a UK-founded enterprise software company with global ambitions sees London as capable of supporting its next stage. Quantexa does not need to decide immediately, but the fact that the US remains an equally serious option shows how much work Britain’s public markets still have to do to retain their own technology successes.












